| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Jun―04 |
Potential Inhibitors of SARS-CoV-2 Developed through Machine Learning, Molecular Docking, and MD Simulation |
Arshiya Khan, Anushka Bhrdwaj, Khushboo Sharma, Ravali Arugonda, Navpreet Kaur, Rinku Chaudhary, Uzma Shaheen, Umesh Panwar, V. Natchimuthu, Abhishek Kumar, Taniya Dey, Aravind Panicker, Leena Prajapati, Nhattuketty Krishnan Shainy, Muhammed Marunnan Sahila, Francisco Jaime Bezerra Mendonça Junior, Tajamul Hussain, Salman Alrokayan, Anuraj Nayarisseri |
| 2 |
[GO] |
2025―Apr―25 |
Curcumin-Based Virtual Screening Identifies Inhibitors of SARS-CoV-2 Spike Protein and ACE2 Receptor Binding |
Timoteo Delgado-Maldonado, Luis D. Gonzalez-Morales, Gilberto Vargas-Salas, Guadalupe Rojas-Verde, Eyra Ortíz-Pérez, Alma D. Paz-Gonzalez, Gildardo Rivera |
| 3 |
[GO] |
2024―Nov―29 |
Identification of Potential FDA-Approved Inhibitors of SARS-CoV-2 Helicase Through a Multistep In Silico Approach: A Promising Prospect for COVID-19 Treatment |
Ibrahim H. Eissa, Eslam B. Elkaeed, Alaa Elwan, Aisha A. Alsfouk, Ahmed M. Metwaly |
| 4 |
[GO] |
2024―Jul―23 |
Chemically Synthesized 1,2,3,4,6-Pentakis-O-Galloyl-β-D-Glucopyranoside
Blocks SARS-CoV-2 Spike Interaction with Host ACE-2 Receptor |
Jazmine Ezell, Rami A. Al-Horani |
| 5 |
[GO] |
2024―Feb―03 |
Systematic Review On Major Antiviral Phytocompounds from Common
Medicinal Plants Against SARS-CoV-2 |
Suvendu Ghosh, Partha Singha, Lakshmi Kanta Das, Debosree Ghosh |
| 6 |
[GO] |
2024―Jan―11 |
Structure-based Virtual Screening from Natural Products as Inhibitors of
SARS-CoV-2 Spike Protein and ACE2-h Receptor Binding and their
Biological Evaluation In vitro |
Timoteo Delgado-Maldonado, Luis Donaldo Gonzalez-Morales, Alfredo Juarez-Saldivar, Edgar E. Lara-Ramírez, Guadalupe Rojas-Verde, Adriana Rodriguez-Moreno, Debasish Bandyopadhyay, Gildardo Rivera |
| 7 |
[GO] |
2023―Nov―10 |
Determination of Novel SARS-CoV-2 Inhibitors by Combination of
Machine Learning and Molecular Modeling Methods |
Ersin Güner, Özgür Özkan, Gözde Yalcin Ozkat, Süreyya Ölgen |
| 8 |
[GO] |
2023―Apr―18 |
An in silico investigation to identify promising inhibitors for SARS-CoV-2 Mpro target |
V. Alagarsamy, P. Shyam Sundar, B. Narendhar, M. T. Sulthana, Vishaka S. Kulkarni, A. Dharshini Aishwarya, V. Raja Solomon, S. Murugesan, S. Jubie, K. Rohitha, Sangeetha Dhanwar |
| 9 |
[GO] |
2023―Feb―28 |
Recent Advances in N-Heterocycles for COVID-19 Treatment- A Mini Review |
Monica Dinodia |
| 10 |
[GO] |
2022―Okt―18 |
The Coronavirus Epidemic |
A. Hilgeroth |
| 11 |
[GO] |
2022―Okt―12 |
Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2? |
Igor José dos Santos Nascimento, Ricardo Olimpio de Moura |
| 12 |
[GO] |
2022―Aug―30 |
An Insight into COVID-19 and Traditional Herbs: Bangladesh Perspective |
Abdur Rauf, Md. Mominur Rahman, Sheikh Shohag, Md. Rezaul Islam, Shomaya Akhter, Sadia Afsana Mim, Rohit Sharma |
| 13 |
[GO] |
2022―Jun―17 |
Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in Development of COVID-19 |
Lok Yong Hui, Chan Sook Mun, Lai Cong Sing, Harish Rajak, Rohini Karunakaran, Veerasamy Ravichandran |
| 14 |
[GO] |
2022―Feb―14 |
Recent Development of Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery |
Sujit Mahato |
| 15 |
[GO] |
2021―Aug―09 |
Structural bioinformatics used to predict the protein targets of remdesivir and flavones in SARS-CoV-2 infection |
Avram Speranta, Laura Manoliu, Catalina Sogor, Maria Mernea, Corina Duda Seiman, Daniel Duda Seiman, Carmen Chifiriuc |
| 16 |
[GO] |
2021―Jun―21 |
Discovery of a “Cocktail” of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. (“Lagundi”) |
Ruel Cayona, Evelyn Creencia |
| 17 |
[GO] |
2021―Feb―10 |
Coumarins and Quinolones as Effective Multiple Targeted Agents Versus Covid-19: An in Silico Study |
Mojgan Nejabat, Razieh Ghodsi, Farzin Hadizadeh |
| 18 |
[GO] |
2020―Jul―28 |
In silico study to evaluate the antiviral activity of novel structures against 3C-like protease of Novel Coronavirus (COVID-19) and SARS-CoV |
Kiran Chunduru, Runali Sankhe, Farmiza Begum, Nalini Sodum, Nitesh Kumar, Anoop Kishore, Rekha R. Shenoy, C. Mallikarjuna Rao, Kavitha Saravu |
| 19 |
[GO] |
2020―Apr―18 |
The Coronavirus Epidemic |
A. Hilgeroth |
